Emglif 25 mg (Tablet)
Unit Price: ৳ 45.00 (1 x 10: ৳ 450.00)
Strip Price: ৳ 450.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Orion pharma ltd |
| Also available as |
Title
- Emglif 25 mg Tablet
Categories
- Medicine
- Diabetes Control
- Cardiovascular Health
Description
- Emglif is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- It also helps to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Dosage & Administration
- Recommended dose is 10 mg once daily, taken in the morning, with or without food.
- In patients tolerating Emglif, the dose may be increased to 25 mg once daily.
- Correcting volume depletion prior to initiation is recommended.
Pharmacology
- Sodium glucose co-transporter-2 (SGLT-2) inhibitor
- Reduces hyperglycemia
- Assists in weight loss
- Lowers blood pressure
Interaction
- Co-administration with diuretics increases urine volume.
- Co-administration with insulin or insulin secretagogues increases the risk for hypoglycemia.
- SGLT2 inhibitors increase urinary glucose excretion and will lead to positive urine glucose tests.
- Monitoring glycemic control with 1,5-AG assay is not recommended.
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients.
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
- Not recommended when breastfeeding.
Precautions & Warnings
- Assessment of renal function recommended prior to initiation and periodically thereafter.
- Not initiated in patients with an eGFR less than 45 ml/min/1.73 m².
- No dose adjustment needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m².
Overdose Effects
- Supportive measures such as removing unabsorbed material from the gastrointestinal tract and clinical monitoring should be employed.
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
Common Questions
- What is Emglif 25 mg Tablet?
- What is Emglif 25 mg Tablet used for?
- Are there any pregnancy warnings?
- Are there any breast-feeding warnings?
- Does this affect kidney function?
- Does this affect liver function?
- Quick Tips
Additional Information
- Empagliflozin contributes to reduced hyperglycemia, assists in weight loss, and reduces blood pressure.
- No dose adjustment is needed for patients with mild to moderate liver disease.
Overdose Treatment
- Removal of Emglif by hemodialysis has not been studied.
Compound Summary
- Chemical Structure: (Image of chemical structure)